T he renin-angiotensin system is intrinsic to the brain and plays a critical role in the control of blood pressure (BP) and body fluid homeostasis. Angiotensin II (AngII) is a potent vasoconstrictor, a major culprit in the genesis of hypertension, and coordinates a range of interrelated functions, such as blood volume and arterial pressure.
T he renin-angiotensin system is intrinsic to the brain and plays a critical role in the control of blood pressure (BP) and body fluid homeostasis. Angiotensin II (AngII) is a potent vasoconstrictor, a major culprit in the genesis of hypertension, and coordinates a range of interrelated functions, such as blood volume and arterial pressure. 1 This multifunctional peptide produces its effect predominantly through the AT 1 receptors (AT 1 Rs). Circulating AngII also exerts its actions on BP control and body fluid homeostasis, through stimulation of AT 1 R in the circumventricular organs lacking a blood-brain barrier, thereby activating hypothalamic and brain stem sites and contributing to sympathoexcitation and the hypertensive response. 2 The nucleus of solitary tract (NTS) is a primary sensory nucleus involved in processing of sensory information from visceral afferent nerves including the cardiovascular receptors. The medial NTS is particularly important in receiving and processing baroreceptor inputs from the aortic arch and carotid sinus regions. Studies have revealed an unequivocal effect of AngII in this brain area in regulation of synaptic transmission and baroreceptor sensitivity. 3 For example, AngII can trigger nitric oxide release from the endothelium, which can depress the baroreflex function. 3 However, the effects of AngII on BP regulation in the NTS remain a subject of debate because microinjection of AngII into the medial NTS can result in either a depressor or a pressor effect, dependent on the experimental design. 4, 5 In addition, microinjection of AngII into the NTS induces an inconsistent effect on heart rate. 3, 6 Nonetheless, all these effects are mediated by AT 1 R because they can be attenuated by blockade of AT 1 R. 3, 7 Recent evidence suggested an association between the neurogenic hypertension and an inflammatory condition, wherein the proinflammatory cytokines, such as the tumor necrosis Abstract-AT 1 receptor subtype a (AT 1 Ra) expression is increased in the nucleus of the solitary tract (NTS) in spontaneously hypertensive rat (SHR) compared with Wistar Kyoto controls. However, the chronic role of AT 1 Ra in the NTS for cardiovascular control is not well understood. In this study, we investigated the hypothesis that the NTS AT 1 Ra is involved in the neural regulation of the peripheral inflammatory status and linked with hypertension. Transduction of brain neuronal cultures with recombinant adeno-associated virus type 2 (AAV2)-AT 1 R-small hairpin RNA (shRNA) resulted in a 72% decrease in AT 1 Ra mRNA and attenuated angiotensin II-induced increase in extracellular signal-regulated kinase 1/2 phosphorylation and neuronal firing. Specific NTS microinjection of AAV2-AT 1 R-shRNA vector in the SHR resulted in a ≈30 mm Hg increase in the mean arterial pressure compared with control vector-injected animals (Sc-shRNA: 154±4 mm Hg; AT 1 R-shRNA: 183±10 mm Hg) and induced a resetting of the baroreflex control of heart rate to higher mean arterial pressure. In addition, AAV2-AT 1 factor-α, contribute to the hypertensive effect. 8 In support of this, AngII infusion increases proinflammatory cytokines and renin-angiotensin system blockade attenuates circulating and tissue levels of cytokines in cardiovascular diseases. 2 Consistent with this view is the evidence of the involvement of T-cell activation in AngII-induced hypertension. 9 In addition, the expression of AngII and AT 1 R is increased in the brain cardioregulatory areas, including the NTS, of the spontaneously hypertensive rat (SHR) compared with its normotensive Wistar Kyoto (WKY) control. 10, 11 Taken together, these observations suggest that the brain AngII and AT 1 R may be involved in the development of peripheral inflammation and vasculature damage, compounding the condition of hypertension. Thus, we hypothesize that increased AT 1 R expression in the NTS affects BP and influences inflammatory status in the circulation. We tested this hypothesis by chronic knockdown of the NTS AT 1 R by recombinant adeno-associated virus type 2-AT 1 R-small hairpin RNA (AAV2-AT 1 R-shRNA) mediated gene transfer.
Materials and Methods
An expanded Materials and Methods section is available in the online-only Data Supplement.
Results

Characterization of AAV2-AT 1 R-shRNA
There are 2 subtypes of AT 1 R expressed in the NTS: AT 1 Ra and AT 1 Rb. We decided to target AT 1 Ra gene because our real-time polymerase chain reaction result showed that >98% AT 1 R in the NTS is AT 1 Ra, and AT 1 Ra mRNA levels were significantly increased in adult SHR compared with age-matched normotensive WKY controls ( Figure S1 in the online-only Data Supplement). A small hairpin RNA-targeted AT 1 Ra was cloned into an AAV vector under the control of human U6 promoter ( Figure 1A ). Infection of SHR brain neuronal cultures with the AAV2-AT 1 R-shRNA showed a robust transduction as evidenced by green fluorescent protein expression ( Figure 1B ). This transduction resulted in a 72% decrease in the AT 1 Ra mRNA levels compared with AT 1 Ra mRNA levels in control vector, AAV2-Sc-shRNA, transduced neurons, whereas there was no significant change in AT 1 Ra mRNA levels between AAV2-Sc-shRNA-treated neurons and phosphate-buffered solution-treated control ( Figure 1C ). In addition, AAV2-AT 1 R-shRNA transduction abolished extracellular signal-regulated kinase 1/2 phosphorylation induced by AngII ( Figure 1D ). Furthermore, AT 1 R-shRNA infection diminished AngII-induced increase in action potential frequency ( Figure  1E ). These observations confirmed the efficacy of the AAV2-AT 1 R-shRNA on AT 1 Ra knockdown.
AT 1 Ra Knockdown Increases MAP and Alters Baroreflex in the SHR
Transduction of SHR NTS with AAV2-AT 1 R-shRNA resulted in an increase in mean arterial pressure (MAP) compared with AAV2-Sc-shRNA-treated rats. This increase was first apparent 28 days, reached peak values 49 days after microinjection, and was maintained until the termination of the protocol (Sc-shRNA: 154±4 mm Hg; AT 1 R-shRNA: 183±10 mm Hg). In contrast to SHR, an identical microinjection of AAV2-AT 1 R-shRNA in WKY rats did not affect MAP (Figure 2A ).
No significant changes were observed in heart rate between AT 1 Ra knockdown rats and control animals in both SHR and WKY rats (Figure 2A ). Quantitative real-time polymerase chain reaction showed that a modest but insignificant decrease in the AT 1 Ra mRNA levels was observed 7 days after AT 1 RshRNA transduction. This decrease became significant by 21 days (42%), reached almost maximal levels at 35 days (≈45%), and was maintained until the end of the study (50%; Figure  2B ). However, AT 1 Rb mRNA levels did not change by chronic AT 1 Ra knockdown (data not shown). Baroreflex function assay in the SHR showed that knockdown of the NTS AT 1 R triggered a shift in the MAP-heart rate curve upward and to the right associated with significant increases in the operating point, maximal gain, lower plateau, upper plateau, saturation, and threshold levels. However, the average gain from the linear part of the slope was unchanged by AT 1 R-shRNA ( Figure 2C ; Figure S1 ). Spectral analysis indicated that the sympathetic vasomotor drive, very low frequency (VLF), was significantly increased in the AT 1 Ra knockdown SHR ( Figure S2 ).
AT 1 Ra Knockdown Heightened the Cardiac Hypertrophy in the SHR
Animals were euthanized at the end of the experiments and body weight/heart weight ratio was measured. Significant increases in body weight to heart weight were observed in the AT 1 Figure S3 ).
AAV2-AT 1 R-shRNA Vector Primarily Targets the NTS Neurons
Animals were euthanized at the end of the experiment. Coronal sections of brain stem containing the NTS were used for immunostaining using antibodies specific for neuronal nucleus (NeuN), astrocyte (glial fibrillary acidic protein; GFAP), and microglia (Iba1) to identify AT 1 R-shRNA-transduced cell type(s). We observed that green fluorescent protein, a reporter gene in AAV2-AT 1 R-shRNA viral vector, was primarily colocalized with neuronal nucleus, but not with glial fibrillary acidic protein and Iba1-positive cells (Figure 3) .
Quantitative real-time polymerase chain reaction showed that AT 1 Ra mRNA levels were ≈50% less in the NTS of AAV2-AT 1 R-shRNA-treated SHR and WKY rats compared with their control vector administration animals. However, no changes in the AT 1 Ra mRNA were observed in other brain areas such as the paraventricular nucleus (PVNs; Figure S4 ).
AT 1 Ra Knockdown Increases Inflammatory Cells and Decreases Endothelial Progenitor Cells in the Blood of SHR
Circulating endothelial progenitor cell (EPC) and inflammatory cell (IC) levels in mononuclear cells fractions were analyzed using fluorescence-activated cell sorting. We selected CD90
as a marker for rat EPCs based on previously published reports. 12 We observed a 74% decrease in EPCs; a 300% increase in CD4
, and a 235% increase in CD68 + in the ATR knockdown SHR (all P<0.05). This resulted in 8-to 15-fold decrease in circulating EPC/IC ratio ( Figure 4 ). There were no significant changes observed between AT 1 Ra knockdown WKY rats and control animals ( Figure S5 ).
Discussion
The present study examines the physiological outcome of chronic knockdown of the AT 1 Ra in the NTS and reveals 2 novel findings: (1) decreased NTS AT 1 Ra mRNA in the SHR results in an elevation in MAP and the sympathetic vasomotor drive, and the baroreflex resetting to higher levels of arterial pressure, altering the operating range of MAP without changing the buffering capacity of the baroreflex. These data indicate that AT 1 Ra plays an important role in the maintenance of the set point of arterial pressure and that its upregulation in the NTS has a restraining influence on chronic MAP in the SHR. Although the role of the AT 1 R in cardiovascular function has been extensively investigated, most studies were carried out in an acute experimental situation and with the use of anesthetized animals. 13, 14 Here, we demonstrate a profound effect of a specific and chronic AT 1 Ra downregulation in the NTS of conscious SHR, which resulted in an elevation in MAP and caused baroreflex resetting in the SHR exclusively. Considering that the AT 1 Ra upregulation in the NTS occurred only in the adult SHR and that knockdown of the AT 1 Ra did not affect the MAP in normotensive WKY rats, we conclude that the elevated AT 1 Ra expression in the NTS of SHR may be a compensatory mechanism of hypertension and has a beneficial inhibiting effect to further BP elevation, as we had recently proposed. 15 The restraining influence of certain types of NTS neurons on chronic arterial pressure has previously been reported. 15 For example, the expression of the phosphatidylinositide 3-kinases, a key enzyme involved in AngIImediated neuronal signaling, is significantly increased in both the NTS and the PVN of SHR compared with WKY rats. 15, 16 However, chronic neuronal blockade of phosphatidylinositide 3-kinases in the NTS is prohypertensive, 15 whereas in the PVN of SHR it is antihypertensive. 16 Similarly, our recent studies demonstrate that the prorenin receptor, a new member of brain renin-angiotensin system, is elevated in the NTS and supraoptic nucleus of SHR compared with normotensive WKY rats. Chronic knockdown of the prorenin receptor in the SHR NTS induces pressor effect, 17 whereas it causes depressor effect in the supraoptic nucleus. 18 The opposing effects of activation of NTS versus PVN/supraoptic nucleus are generally attributed to the notion that the NTS is considered an inhibitory cardioregulatory nucleus, as its activation (eg, by baro-input) reduces the arterial pressure, whereas the activation of the excitatory cardioregulatory nuclei such as PVN/supraoptic nucleus increases the arterial pressure. 19 Thus, we believe that similar to the phosphatidylinositide 3-kinases and prorenin receptor, upregulation of AT 1 Ra in certain neuronal types within the NTS may promote compensatory activation of the NTS because the system attempts to restore the cardiovascular homeostasis and prevent even higher BP development.
How is the NTS AT 1 Ra involved in BP regulation? One of the mechanisms may involve neural regulation of the activity of certain immune organs such as the bone marrow and spleen. Recent evidence has demonstrated a direct neuronal connection between the brain cardioregulatory areas and the bone marrow. [20] [21] [22] As we have previously shown, the AngIImediated effects in the brain cardioregulatory areas result in the dysfunctional brain-bone marrow communication, which contributes to the development and establishment of hypertension by elevating the circulating ICs and downregulating the EPC levels. 21, 22 Similarly, direct sympathetic innervations of the spleen and the central AngII-dependent increase in the splenic sympathetic nerve activity are directly related to the enhanced splenic immune response, characterized by elevated IC levels. 23, 24 On the contrary, stimulation of the vagus nerve exerts anti-inflammatory effects, by decreasing the levels of the inflammatory cytokines and suppressing the activation of ICs. 25 This is relevant to the present study, considering that AngII is a well-known contributor to the dysfunctional vagal reflex in hypertension. 25 Therefore, dysfunctional AT 1 Ra signaling in the NTS may be directly involved in the disruption of autonomic nervous system-immune system communication and induces hypertension.
The brain also exhibits heightened inflammatory status in the hypertensive animal models, and the inflammatory processes in the brain cardioregulatory regions are linked with modulation of the autonomic nervous system and increased BP. 20, 22, 26 The NTS itself is characterized by accumulation of different ICs and by elevated cytokine levels in the SHR, which may influence the NTS neuronal activity and induce sympathoexcitation. 22 Increased expression of the NTS AT 1 Ra in the SHR may serve as a counterhypertensive mechanism and attempts to decrease the sympathetic drive. Chronic knockdown of the NTS AT 1 Ra increases the sympathetic vasomotor drive. In turn, this increased sympathetic outflow may directly influence the activity of the bone marrow activity, 22 as well as the spleen, 9, 23, 24 contributing to the decrease in the EPCs and increase in the ICs, as previously described, 21 which may subsequently contribute to BP elevation. Although we do not present direct evidence in the present study to demonstrate that increase in ICs precedes BP changes and induces BP elevation, all existing evidences suggest that inflammation may occur earlier and is critical in the initiation and establishment of hypertension: (1) studies led by Drs Harrison's and Abboud's groups have indicated that increased inflammatory precedes hypertensive state 9, 27 ; (2) our recent studies have shown a timedependent increase in bone marrow-derived ICs and decrease in EPCs in AngII infusion rat model; inhibition of brain ROS, which attenuates high BP and also corrects this EPCs/ICs imbalance. These changes in ICs and EPCs in AngII model of hypertension seems to be centrally mediated because increase in BP by chronic phenylephrine infusion fails to influence EPCs/ICs balance 21 ; and (3) our unpublished data shows significant increase in ICs in prehypertensive SHR. Furthermore, increasing evidence demonstrates the role of macrophages and T cells in the development and establishment of hypertension. Mice lacking T lymphocytes do not develop hypertension and the associated vascular dysfunction, and genetic deletion of macrophages markedly reduces experimental hypertension. 9 However, our present study does not establish whether the correction of the EPC/IC imbalance would attenuate the increase in BP and presently renders the suggested connection among the NTS AT 1 Ra knockdown, the increase in BP, and the EPC/ IC imbalance purely correlative. Further investigation is warranted in support of this hypothesis.
Taken together, knockdown of the NTS AT 1 Ra increases sympathetic outflow to the periphery, which results in further elevation of BP in the SHR. This is associated with increases in the circulating macrophages and T cells and decreases in the EPC levels. This may further increase the inflammatory status and compromise the reparative capacity of the vasculature damaged by hypertension. Ultimately, these synergistic effects of the dysfunctional autonomic nervous system and overactive immune system may lead to deterioration in hypertension, as previously suggested.
9,27
Perspectives
The present study reveals a novel role for AT 1 Ra in the NTS of SHR in modifying peripheral inflammation and restraining the BP. Future studies should seek to determine the modulatory factors that enhance the AT 1 Ra effect. Such information might allow the development of new tools for specific activation of NTS AT 1 Ra, which may provide a powerful intervention to lower arterial pressure chronically and perhaps decrease hypertension-dependent peripheral inflammation.
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None. • Chronic knockdown of the nucleus of the solitary tract AT 1 receptor subtype a in the conscious spontaneously hypertensive rat elevates blood pressure (BP) and shifts the set point of arterial pressure to a higher level. This increase in BP is accompanied by a decrease in endothelial progenitor cells and an increase in inflammatory cells, including the macrophages and T lymphocytes in the blood.
What Is Relevant?
• The nucleus of the solitary tract AT 1 receptor subtype a participates in the regulation of sympathetic nervous system, and it is involved in the control of set point of arterial pressure.
Summary
Chronic knockdown of the nucleus of the solitary tract AT 1 receptor subtype a in the spontaneously hypertensive rat increases neuronal activity and sympathetic outflow, leading to increased BP. This increase in BP is accompanied by decreased endothelial progenitor cells and increased inflammatory cells, which may further contribute to the hypertensive phenotype. These data suggest that the increased AT 1 receptor subtype a in the nucleus of the solitary tract of spontaneously hypertensive rat is a compensatory mechanism of hypertension because it acts to inhibit further BP elevation. 
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Supplement Materials Chronic Knockdown of the NTS AT1R Increases blood Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR
Materials and Methods
Animals
All Spontaneously Hypertensive Rats (SHR) and Wistar Kyoto (WKY) rats were purchased from Charles River Laboratories (Wilmington, MA). They were housed individually and kept on a 12h: 12 h light-dark cycle in a climate-controlled room. Rat chow (Harlan Tekland) and water were provided ad libitum. All the animal experiments followed protocols approved by the University of Florida Institutional Animal Care and Use Committee.
The effect of in vivo AT1R-shRNA delivery into the NTS on blood pressure and cardiovascular function
Seven-week-old male SHR (MAP<120 mmHg) or WKY rats (MAP=90~100 mmHg) were anesthetized and telemetry transmitters were implanted into the abdominal aorta as described previously 1 . Following recovery for 7 days, animals were randomly divided into two groups, and were used for bilateral injection into the NTS spanning ±500 μm rostrocaudal to calamus scriptorius, 500 μm from the midline, and 500 μm ventral to the dorsal surface 2 with 0.2 µl/side of AAV2-AT1R-shRNA, or AAV2-Sc-shRNA (2x10 8 genome containing virus particles). Mean arterial pressure (MAP) and heart rate (HR) were monitored via telemetry transducers. 10-week following microinjection, baroreflex function was measured and then animals sacrificed for analysis of plasma norepinephrine (NE), vasopressin (AVP), circulating endothelial progenitor cells (EPCs), inflammatory cells (ICs) and gene transduction as described in this section. A full spectral analysis of the BP signal, sampled at 1000Hz, was performed to reveal potential autonomic mechanisms as described previously 2
The NTS dissection
Rats were euthanized, brains were dissected, fresh brainstem tissue was transected coronally at the level of the NTS, which was identified as a distinct translucent structure in the dorsomedial medulla. At the level of the area postrema, a 0.5-1 mm-diameter rostro-caudally (~0.5 mm thick) piece of NTS was punched out bilaterally using fine tip forceps under a binocular microscope.
Measurement of the AT1Ra mRNA levels by RT-real-time PCR
Rats were euthanized, brains were collected, the NTS regions were dissected and subjected to RNA isolation, using RNeasy plus mini kit (Qiagen, Valencia, CA, USA) following the manufacturer's instructions. RNAs were reverse transcribed with iScript TM cDNA synthesis kit (BioRad, Hercules, CA, USA). The AT1Ra mRNA levels were analyzed by quantitative realtime PCR using AT1R specific primers and probe (Applied Biosystems, Foster City, CA, USA) in the PRISM 7000 sequence detection system (Applied Biosystems). All cDNA samples were assayed in triplicate. Data were normalized to 18S RNA, or GAPDH gene.
Measurement of AT1Ra and AT1Rb using conventional reverse-transcriptional PCR
RNAs were isolated from the NTS samples of 12-week-old SHR and 200 ng of RNA was used to perform reverse-transcriptional PCR in a 20 µl reaction system to obtain cDNA. These cDNA samples were used as the templates to amplify AT1Ra (primer-F: 5'-GCTTCAACCTC TACGCCAGTGT-3'; primer-R: 5'-TCAGCACATCCAGGAAAGTGAA-3') and AT1Rb (primer-F: 5'-GCCAGCGTCAGTTTCAATCTCT-3', primer-R: 5'-GGATAATGCCCAGC TGAATGAG-3'). The PCR reaction system ( 20 µL) containing 10 µL of Hotstar Taq plus master mix (Qiagen, Valencia, CA, USA), 1 μL of cDNA, and a pair of primers for either AT1Ra or AT1Rb at final concentration of 1 μM. Amplification conditions for both genes were as follows: 95 for 5 minutes; 35 cycles at 95 for 45 seconds, 60 for 45 seconds and 72 for 1 minute, and a final extension cycle of 72 for 10 minutes. The 5 µL of PCR products were analyzed by 1.5% agrose gel electrophoresis. The PCR product for AT1Ra is 471bp; for AT1Rb is 499 bp.
Preparation of neuronal cells in primary cultures from SHR brains
Neuronal cells in primary culture were established from the hypothalamus and brainstem of one-day-old SHR as described previously 3, 4 . Neuronal cultures containing more than 95% neurons (remaining cells are primarily astroglia).
Plasmid construction and production of AAV vectors containing AT1R-shRNA
A synthetic complementary DNA encoding shRNA targeted AT1Ra mRNA (GCAGGCACAGTTACATATTTG) or scrambled (Sc) DNA, containing the same nucleotides as the AT1R-shRNA DNA template but in a completely different arrangement and not targeting any rat gene, was designed and cloned into an AAV vector, PTR-UF11, under the control of human U6 promoter ( Figure 1A) . A GFP reporter gene under the control of CBA promoter was cloned upstream of the shRNA expression cassette in order to directly visualize expression from the vector after delivery, generating construct AAV-AT1R-shRNA or control vector, AAVSc-shRNA. The constructs were packaged into the AAV2, and virus production and titers were determined as previously described 5 .
AAV2-AT1R-shRNA vector infection in primary neuronal culture and measurement of phosphorylation of ERK1/2 MAP kinases
Seven-day-old neuronal cultures were incubated with either AAV2-AT1R-shRNA (MOI=1:500) or AAV2-Sc-shRNA (MOI=1:500), or the same volume of PBS. Five days following infection, cells were collected, and used for RNA isolation and subsequent RT-quantitative PCR for AT1Ra mRNA assay. In another set of experiment, cells were treated with Ang II (100 nmol/mL) for 5 minutes, subjected to protein isolation and subsequent Western blotting to measure ERK1/2 phosphorylation. The ratio of phosphorylated ERK1/2 to total ERK1/2 MAP kinases was analyzed as described previously 
Electrophysiology:
Seven-day-old primary neuronal cultures were transduced with AAV2-AT1R-shRNA or AAV2-Sc-shRNA. Five days following transduction, neurons expressing GFP were selected for current clamp electrophysiological recordings, as described previously 4 .
Baroreflex analysis:
Ten-week following AAV2-AT1R-shRNA or AAV2-Sc-shRNA microinjection, all animals were anesthetized to implant a catheter into the femoral vein for drug injections. The catheter was tunneled subcutaneously into the back of the neck to allow access when the animal was conscious. Measurements of MAP and HR were made via telemetry transducers. To assess baroreflex control of HR, depressor and pressor tests were performed using intravenous bolus injections of sodium nitroprusside (0.25, 0.5 and 1.0µg) and phenylephrine (0.25, 0.5 and 1.0µg) to decrease and increase MAP by 15-60 mmHg, respectively. The relationship between changes in MAP and changes in HR was evaluated by linear regression analysis and logistic function. The slope (gain coefficient) was determined by fitting a linear regression through the points over the range of pharmacologically induced bradycardia and tachycardia responses as described previously 6 . The logistic sigmoidal curve of best fit was described by the following 4 where y is HR, x is MAP, A 1 is the y range, A 2 is the gain coefficient, A 3 is MAP at the midpoint (operating point), and A 4 is y at the bottom plateau. The function curves were constructed as described previously 7, 8 and the goodness of fit of each sigmoidal curve to the raw data points was measured by the correlation coefficient (R 2 ).
Mononuclear cells (MNC) Isolation and fluorescence activated cell sorting (FACS):
Rats were subjected to anesthesia with isoflurane and blood was drawn from abdominal vein. The blood was diluted with PBSFE (PBS containing 2%FBS and 1mM EDTA) buffer followed by the addition of 10 ml of Ficoll-Paque (GE Healthcare). Yellow buffy coat was obtained after centrifugation at 300 x g for 25 minutes and was transferred to a new tube to isolate mononuclear cell (MNC) pallet. Ammonium chloride (Stem Cell Technology) was added and incubated for 10 min on ice to remove residual red blood cells in the pellet. Cells were collected and washed twice with PBSFE to remove residual ammonium chloride. All data are expressed as mean ± S.E.M. Statistical significance was evaluated with the use of one-way ANOVA, two-way ANOVA and unpaired Student's t test. Differences were considered to be significant at p < 0.05. Figure S1 A, RT-real-time PCR assay showed that AT1Ra mRNA level is ~60 fold higher than AT1Rb in the NTS of 12-week-old SHR (left) and conventional RT-PCR showed that AT1Ra band is much stronger than AT1R b (Right). B. AT1Ra mRNA levels were ~2-fold higher in the NTS of 12-week-old SHR compared to age matched WKY rats, but there is no significant change between 5-week-old pre-hypertensive SHR (MAP≤110 mm Hg) and age-matched WKY rats. A. a representative image showing that the heart from AT1Ra knockdown SHR is bigger compared to control vector treated SHR, AT1R-shRNA treated WKY rats, and control WKY rats (left panels), right panel showed heart weight (HW) to body weight (BW) ratio was increased in the AT1R-shRNA treated SHR compared to control animals (AT1R-shRNA: 0.44±0.02%, Sc-shRNA: 0.38±0.01%, *P<0.05), but not in WKY rats (AT1R-shRNA: 0.33±0.01%; Sc-shRNA: 0.32±0.01%, P>0.05). B. AT1R knockdown resulted in an increase in cardiomyocyte size of left ventricle in the SHR. Left panels were representative micrographs of hematoxylin and eosin strained left ventricle section, right panel showed that quantification of cardiomyocyte size was increased in the AT1R-shRNA treated SHR compared to Sc-shRNA treated animal (AT1R-shRNA: 2.55±0.17; Sc-shRNA: 1.73±0.09 µm, P<0.05).
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Figure S4 
